Products found to contain undeclared medicines
|
|
The United States: Public Notification: Platinum Weight Loss Solution – Fat Loss Metabolizer contains hidden drug ingredients sibutramine and phenolphthalein |
|
The Food and Drug Administration (FDA) is advising consumers not to purchase or use Platinum Weight Solution – Fat Loss Metabolizer, a product promoted and sold for weight loss on various Web sites and possibly in some retail stores.
FDA laboratory analysis confirmed that Platinum Weight Solution – Fat Loss Metabolizer contains sibutramine. Sibutramine is a controlled substance that was removed from the market in October 2010 for safety reasons. The product poses a threat to consumers because sibutramine is known to substantially increase blood pressure and/or pulse rate in some people and may present a significant risk for people with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke. This product may also interact, in life-threatening ways, with other medications a consumer may be taking.
Laboratory analysis also confirmed that Platinum Weight Solution – Loss Metabolizer contains phenolphthalein. Studies have indicated that it may be associated with an increased risk of cancer.
Please refer to the following website in FDA for details:
http://www.fda.gov/Drugs/ResourcesForYou/../ucm539783.htm
In Hong Kong, the above product is not a registered pharmaceutical product.
Ends/ Saturday, February 4, 2017
Issued at HKT 12:00
|
|
|